Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)

SHA:605266 Revenue

Jianzhijia Pharmaceutical Chain Group had revenue of 2.09B CNY in the quarter ending June 30, 2026, a decrease of -3.25%. This brings the company's total for the last twelve months to 8.65B, down -6.56% year-over-year. In the year 2025, Jianzhijia Pharmaceutical Chain Group had annual revenue of 8.92B, down -3.90%. That makes Jianzhijia Pharmaceutical Chain Group the 6,542nd largest company in the world by revenue and 917th in China.

• Revenue (ttm): 8.65B
• Revenue Growth: -6.56%
• P/S Ratio: 0.26
• Revenue / Employee: 537.70K
• Employees: 16,082
• Market Cap: 2.27B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Retail and Services 8.49B 95.2%
• Convenience Sales Section 410.79M 4.6%
• Others 11.47M 0.1%
• Wholesale Sales 10.29M 0.1%

Fiscal year ended Dec 31, 2025 See the full SHA:605266 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.92B	-361.88M	-3.90%
Dec 31, 2024	9.28B	202.15M	2.23%
Dec 31, 2023	9.08B	1.57B	20.84%
Dec 31, 2022	7.51B	2.28B	43.54%
Dec 31, 2021	5.23B	768.60M	17.21%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error